4/A
Changes in Ownership
Lucid Diagnostics Inc. Filed Acc 0001062993-23-018551
Director sold 3,917 shares at an average $1.45 ($5,675)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lapidus Stanley Director | 2023-09-20 | Sale 10b5-1 | −3,405 | $1.45 | $4,937 | 132,051 | D |
| Lapidus Stanley Director | 2023-09-20 | Sale 10b5-1 | −412 | $1.44 | $593 | 131,639 | D |
| Lapidus Stanley Director | 2023-09-21 | Sale 10b5-1 | −100 | $1.44 | $144 | 131,539 | D |
| Open-market sales · 3,917 sh · avg $1.45 · $5,675 | |||||||
Loading xslF345X05/form4a.xml…